Elizabeth A. Watkins
@Crescent Grove Advisors, Llc
Latest period2024 - Q3ReportedManaged Assets$980.29MTotal holdings276
Assets growth rate7.41%Assets growth rate (2-Q avg)1.29%Continuous growth in asset value1 quarters
Portfolio positions
This chart displays the top 10 holdings in Crescent Grove Advisors, Llc's 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 276 positions.
Assets under management
The assets under management (AUM) of Crescent Grove Advisors, Llc over the past 10 years (40 quarters) show continuous growth in total asset value over the last 1 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 980.29M in assets, with a quarterly growth rate of 7.41% and a 2-quarter average growth rate of 1.29%. The portfolio is managed by Elizabeth A. Watkins, and others.
Portfolio holdings
Investment | Portfolio % | Reported Value | Recent Activity |
---|---|---|---|
XBISpdr S&p Biotech Etf
| 0.98% | $9.605M 97,218 shares@ $98.8 avg price | Decreased -6.07% |
VYMVanguard High Dividend Yield Etf
| 0.95% | $9.284M 72,421 shares@ $128.2 avg price | Decreased -0.62% |
VYXNcr Voyix
| 0.86% | $8.356M 615,741 shares@ $13.57 avg price | Decreased -21.91% |
XLFFinancial Sector Spdr Etf
| 0.86% | $8.338M 183,979 shares@ $45.33 avg price | Decreased -0.17% |
IWPIshares Russell Mid Cap Growth Etf
| 0.74% | $7.21M 61,469 shares@ $117.29 avg price | Decreased -6.09% |
MSFTMicrosoft
| 0.66% | $6.446M 14,980 shares@ $430.3 avg price | Decreased -5.03% |
IBBIshares Biotechnology Etf
| 0.64% | $6.232M 42,800 shares@ $145.61 avg price | Decreased -1.71% |
VEAVanguard Ftse Developed Markets Etf
| 0.61% | $5.977M 113,183 shares@ $52.81 avg price | Decreased -17.01% |
XLGInvesco S&p 500 Top 50 Etf
| 0.6% | $5.818M 122,414 shares@ $47.53 avg price | Decreased -1.25% |
SPYDSpdr Portfolio S&p (500 High Dividend Etf)
| 0.59% | $5.697M 124,808 shares@ $45.65 avg price | Decreased -7.41% |